Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.

Pharmacogenetics, GlaxoSmithKline, ResearchTriangle Park, NC, USACorrespondence:Dr MR Nelson, Pharmacogenetics,GlaxoSmithKline, 5 Moore Drive, MAI.A1227,Research Triangle Park, NC 27709-3398, USA.E-mail: matthew.r.nelson@gsk.comReceived 18 July 2007; revised 27 November2007; accepted 4 January 2008; publishedonline 26 February 2008